As the United States market navigates a period of volatility, with major indexes closing lower amid concerns over an AI bubble and looming economic reports, investors are keenly observing the tech sector's dynamics. In such a climate, identifying high-growth tech stocks involves looking for companies with strong fundamentals and resilience to market pressures.

Top 10 High Growth Tech Companies In The United States

Name	Revenue Growth	Earnings Growth	Growth Rating
ADMA Biologics	20.12%	23.48%	★★★★★☆
Marker Therapeutics	75.24%	59.07%	★★★★★★
Palantir Technologies	28.00%	32.57%	★★★★★★
Kiniksa Pharmaceuticals International	17.51%	33.44%	★★★★★☆
Workday	11.15%	32.18%	★★★★★☆
Circle Internet Group	23.14%	84.30%	★★★★★☆
RenovoRx	71.45%	71.45%	★★★★★☆
Zscaler	15.85%	45.93%	★★★★★☆
Duos Technologies Group	53.36%	152.11%	★★★★★☆
Procore Technologies	11.76%	116.48%	★★★★★☆

Here we highlight a subset of our preferred stocks from the screener.

Precigen (PGEN)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Precigen, Inc. is a discovery and clinical-stage biopharmaceutical company focused on developing gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases, with a market cap of $1.35 billion.

Operations: Precigen focuses on developing gene and cell therapies using precision technology to address diseases in immuno-oncology, autoimmune disorders, and infectious diseases.

Despite its current unprofitability, Precigen demonstrates promising growth potential with an expected revenue increase of 55.8% per year, outpacing the US market average of 10.5%. This growth is bolstered by significant advancements in biotechnology, as evidenced by the FDA approval of PAPZIMEOS™ for treating recurrent respiratory papillomatosis—a first in its class. The company's commitment to innovation is further highlighted by a substantial R&D investment relative to its revenue, positioning it well for future breakthroughs and financial success in a competitive industry landscape.

Roivant Sciences (ROIV)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Roivant Sciences Ltd. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of medicines and technologies, with a market cap of $15.23 billion.

Operations: Roivant Sciences focuses on the discovery, development, and commercialization of medicines and technologies, generating revenue primarily from these activities. The company has a market cap of $15.23 billion.

Roivant Sciences, amidst a challenging landscape, showcases robust potential with an anticipated 58.5% annual revenue growth, significantly outpacing the U.S. market's average of 10.6%. Despite current unprofitability, earnings are expected to surge by 46.44% annually. Recent strides include positive trial outcomes for Brepocitinib in dermatomyositis and ongoing Phase 2 trials for Mosliciguat in pulmonary hypertension, setting the stage for pivotal FDA filings and commercial launches slated for early 2026 and beyond. These developments underscore Roivant's commitment to addressing critical medical needs through innovative therapies, positioning it favorably within the biotech sector's future landscape.

Semrush Holdings (SEMR)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Semrush Holdings, Inc. offers an online visibility management SaaS platform operating in the United States, the United Kingdom, and internationally with a market cap of approximately $1.77 billion.

Operations: The company generates revenue primarily through its software and programming segment, which brought in $428.63 million. Its operations focus on providing a comprehensive SaaS platform for online visibility management across various regions.

In a significant industry move, Semrush Holdings, recently acquired by Adobe for $2 billion, continues to innovate at the intersection of AI and search engine optimization. Despite a net loss this year, Semrush reported a robust revenue increase to $325.99 million, up from $274.17 million last year, underlining its resilience and adaptability in a rapidly evolving tech landscape. The launch of 'Semrush One' integrates traditional SEO with AI-driven search capabilities, promising enhanced online visibility across various platforms including major LLMs like ChatGPT. This strategic expansion not only diversifies Semrush's offerings but also positions it strongly within the digital marketing sphere as businesses increasingly rely on sophisticated tools to navigate the complexities of internet visibility and brand engagement.

Turning Ideas Into Actions

• Click here to access our complete index of 76 US High Growth Tech and AI Stocks.
• Have a stake in these businesses? Integrate your holdings into Simply Wall St's portfolio for notifications and detailed stock reports.
• Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.

Searching for a Fresh Perspective?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.